Arvinas develops drugs based on targeted protein degradation for treating cancer, pro-inflammatory, autoimmune and rare diseases.
Arvinas, Inc.
[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”ARVN” api=”yf” style=”font-size: 15px”]
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://arvinas.com
Founded2013
Disease Focus
Development Stage
STOCK CODENASDAQ: ARVN
Address5 Science Park 395 Winchester Ave.,CT,6511New HavenUnited States
5 Science Park 395 Winchester Ave.,CT,6511
New Haven
United States
Contact Number+1 203 535 1456
+1 203 535 1456
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/arvinas” connections=”true” suffix=””]